The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns and survival outcomes in metastatic castration-resistant prostate cancer in the Brazilian population: LACOG 1818.
 
Fernando Maluf
Honoraria - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; Ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech
Research Funding - Janssen-Cilag (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Merck Sharp & Dohme
 
Suelen Martins
No Relationships to Disclose
 
Deusdedit Silva Neto
No Relationships to Disclose
 
Daniel Girardi
Consulting or Advisory Role - BMS Brazil; Ipsen; Janssen Oncology
Speakers' Bureau - Adium Pharma; Bayer; BMS Brazil; Ipsen; Janssen; Merck; Pfizer
Travel, Accommodations, Expenses - Adium Pharma; Ipsen; Pfizer
 
Jose Augusto Rinck Jr
No Relationships to Disclose
 
Ana Caroline Alves
No Relationships to Disclose
 
Thiago Almeida
No Relationships to Disclose
 
Andréa de Souza
No Relationships to Disclose
 
Daniel Araujo
Honoraria - AstraZeneca; Libbs; MSD; Novartis; Tersera
Consulting or Advisory Role - MSD Oncology
 
Aline Lara Gongora
No Relationships to Disclose
 
Diogo Bastos
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen-Cilag; MSD
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag; MSD Oncology; MSD Oncology
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen-Cilag
 
Cristina Sampaio
No Relationships to Disclose
 
Augusto Mota
Consulting or Advisory Role - Bayer; Janssen Oncology; Merck; Pfizer
Travel, Accommodations, Expenses - Bayer
 
Andre Fay
No Relationships to Disclose
 
Roberto Rocha
No Relationships to Disclose
 
Douglas Dias e Silva
No Relationships to Disclose
 
Tainá Cabalheiro
No Relationships to Disclose
 
Pablo Barrios
No Relationships to Disclose
 
Gustavo Gössling
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst)
 
Andrey Soares
Honoraria - Adium Pharma; Astellas Pharma; AstraZeneca; Bayer; BMS Brazil; Janssen; Merck Serono; MSD; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Adium Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Adium Pharma; Bayer; Ipsen; Janssen; Merck Serono; MSD